Chongqing Jiasiteng Pharmaceutical Co., Ltd.

Jiasiteng Pharmaceutical Co., Ltd. has an organoid platform. By integrating cutting-edge organoid biotechnology with precision medicine, pharmacy, bioengineering, artificial intelligence and other multidisciplinary technologies, we transform advanced technological achievements into *valuable products and services.
The company has dual-pipeline organoid technologies including tumor organoids (PDO) and iPSC/ESC-derived organoids, continuously delivering diversified products to application scenarios such as precision medicine, drug development, and regenerative medicine. At the same time, the company is the first to combine chip and artificial intelligence technologies with organoids, developing multiple organoid-on-chip products with different design concepts as well as AI-based automation solutions, enabling organoids to achieve standardization, automation, and intelligence, and making them closer to the human body's microphysiological system.
We are committed to transforming advanced technologies into high-quality products that meet the needs of application scenarios. Through our continuously upgraded diversified organoid products and precision treatment supporting drugs, we serve the public and bring value to society and the industry.